封面
市場調查報告書
商品編碼
1701111

疼痛管理設備市場規模、佔有率、成長分析(按產品、應用、最終用途和地區)- 2025-2032 年產業預測

Pain Management Devices Market Size, Share, and Growth Analysis, By Product (Electrical Stimulators, Radiofrequency Ablation Devices), By Application (Neuropathic Pain, Cancer Pain), By End-Use, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2023 年疼痛管理設備市場規模價值為 59.6 億美元,預計將從 2024 年的 65.2 億美元成長到 2032 年的 133.8 億美元,預測期內(2025-2032 年)的複合年成長率為 9.4%。

受慢性疼痛疾病盛行率上升和技術持續創新的推動,疼痛管理設備市場正在快速成長。慢性疼痛影響全球數百萬人,並已成為一項重大的醫療保健挑戰,增加了對有效管理解決方案的需求。各種方法,包括電刺激、射頻消融術和鞘內藥物傳輸系統,擴大被認為是傳統疼痛緩解方法的可行的非藥物替代方法。類風濕性關節炎和癌症等疾病正在推動對持久止痛方法的需求。雖然潛在的併發症和其他風險對市場擴張構成了挑戰,但技術進步正在提高這些設備的有效性和可及性,其價值也得到了患者和醫療保健專業人員的認可,從而確保了該領域的持續成長。

目錄

介紹

  • 調查目的
  • 研究範圍
  • 定義

調查方法

  • 資訊採購
  • 二次資料和一次資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分機會分析

市場動態與展望

  • 市場概覽
  • 市場規模
  • 市場動態
    • 促進因素和機會
    • 限制與挑戰
  • 波特的分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 市場吸引力指數(2024年)
  • PESTEL分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 案例研究
  • 技術進步
  • 監管格局

疼痛管理設備市場規模:依產品及複合年成長率(2025-2032)

  • 市場概覽
  • 電刺激設備
  • 射頻消融術裝置
  • 止痛藥輸液泵
  • 神經刺激設備
  • 其他

疼痛管理設備市場規模:按應用和複合年成長率(2025-2032)

  • 市場概覽
  • 神經病變疼痛
  • 癌症痛
  • 臉部疼痛和偏頭痛
  • 肌肉骨骼疼痛
  • 其他

疼痛管理設備市場規模:依最終用途及複合年成長率(2025-2032)

  • 市場概覽
  • 醫院
  • 門診手術中心
  • 居家照護
  • 其他

疼痛管理設備市場規模:按地區及複合年成長率(2025-2032)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業市場定位(2024年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市場佔有率分析(2024年)
  • 主要企業簡介
    • 公司詳情
    • 產品系列分析
    • 公司分部佔有率分析
    • 收益與前一年同期比較對比(2022-2024 年)

主要企業簡介

  • Medtronic(Ireland)
  • Boston Scientific Corporation(USA)
  • Abbott Laboratories(USA)
  • Stryker Corporation(USA)
  • Becton, Dickinson and Company(USA)
  • Baxter International Inc.(USA)
  • B. Braun SE(Germany)
  • Omron Corporation(Japan)
  • Avanos Medical, Inc.(USA)
  • Teleflex Incorporated(USA)
  • ICU Medical, Inc.(USA)
  • Nipro Corporation(Japan)
  • Moog Inc.(USA)
  • Atricure, Inc.(USA)
  • Micrel Medical Devices SA(Greece)
  • Zynex, Inc.(USA)
  • Enovis Corporation(USA)
  • Stimwave Technologies(USA)
  • SPR Therapeutics(USA)

結論和建議

簡介目錄
Product Code: SQMIG35A2502

Pain Management Devices Market size was valued at USD 5.96 billion in 2023 and is poised to grow from USD 6.52 billion in 2024 to USD 13.38 billion by 2032, growing at a CAGR of 9.4% during the forecast period (2025-2032).

The pain management devices market is experiencing rapid growth, driven by the rising prevalence of chronic pain conditions and ongoing technological innovations. Chronic pain, which impacts millions worldwide, has emerged as a significant healthcare challenge, enhancing the need for effective management solutions. Various methods, including electrical stimulation, radiofrequency ablation, and intrathecal drug delivery systems, are increasingly being recognized as viable non-drug alternatives to traditional pain relief approaches. Conditions like rheumatoid arthritis and cancer are propelling demand for lasting pain relief options. While risks such as potential complications pose challenges to market expansion, advancements in technology are enhancing the efficacy and accessibility of these devices, ensuring continued growth in the sector as both patients and healthcare professionals acknowledge their value.

Top-down and bottom-up approaches were used to estimate and validate the size of the Pain Management Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Pain Management Devices Market Segments Analysis

Global Pain Management Devices Market is segmented by Product, Application, End-Use and region. Based on Product, the market is segmented into Electrical Stimulators, Radiofrequency Ablation Devices, Analgesic Infusion Pumps, Neurostimulation Devices and Others. Based on Application, the market is segmented into Neuropathic Pain, Cancer Pain, Facial Pain and Migraine, Musculoskeletal Pain and Others. Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgery Centers, Home Healthcare and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Pain Management Devices Market

The increasing incidence of chronic pain, particularly among the aging population, significantly drives the demand for pain management devices. Chronic pain stems from various conditions, including arthritis, cancer, and postoperative recovery, becoming increasingly prevalent and necessitating effective management solutions. As patients seek long-term pain relief without relying on opioid medications, both individuals and healthcare providers are actively exploring alternative treatment options. This shift towards non-opioid therapies is contributing to the rising adoption of pain management devices, as they offer innovative solutions to address the growing need for effective and sustainable pain relief strategies in patients' everyday lives.

Restraints in the Pain Management Devices Market

A significant challenge facing the pain management devices market is the elevated cost of these products. High-tech solutions, particularly nerve replacement devices and implant systems, often come with prohibitive price tags that can deter many patients from accessing them. The initial purchase costs are just the beginning; ongoing expenses for maintenance, repairs, and potential replacements further restrict accessibility. This issue is particularly pronounced in low to middle-income regions, where healthcare professionals may be forced to explore more affordable pain management alternatives, limiting the overall potential of advanced pain management technologies in these areas.

Market Trends of the Pain Management Devices Market

The Pain Management Devices market is witnessing a significant shift towards non-invasive solutions, driven by both patient preference and healthcare provider recommendations. Technologies such as Transcutaneous Electrical Nerve Stimulation (TENS) and innovative wearable pain management devices are gaining traction for their ability to deliver effective pain relief without the risks associated with surgical procedures or implants. This growing demand is fueled by benefits such as ease of use, a reduced likelihood of complications, and lower costs compared to invasive alternatives. As new non-invasive devices continue to enter the market, the trend is expected to persist, fundamentally reshaping pain management strategies.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Technology Advancement
  • Regulatory Landscape

Global Pain Management Devices Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Electrical Stimulators
  • Radiofrequency Ablation Devices
  • Analgesic Infusion Pumps
  • Neurostimulation Devices
  • Others

Global Pain Management Devices Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Neuropathic Pain
  • Cancer Pain
  • Facial Pain and Migraine
  • Musculoskeletal Pain
  • Others

Global Pain Management Devices Market Size by End-Use & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Ambulatory Surgery Centers
  • Home Healthcare
  • Others

Global Pain Management Devices Market Size & CAGR (2025-2032)

  • North America (Product, Application, End-Use)
    • US
    • Canada
  • Europe (Product, Application, End-Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Application, End-Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Application, End-Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Application, End-Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Medtronic (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun SE (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Omron Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Avanos Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teleflex Incorporated (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICU Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nipro Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Moog Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Atricure, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Micrel Medical Devices SA (Greece)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zynex, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Enovis Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stimwave Technologies (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SPR Therapeutics (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations